Samuel N. Hazen's Insider Trades & SAST Disclosures
Samuel N. Hazen's most recent trade in HCA Healthcare Inc was a trade of 13,218 Common Stock done . Disclosure was reported to the exchange on Feb. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Samuel N. Hazen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 13,218 | 76,418 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 4,742 | 71,676 (0%) | 0% | 321.9 | 1,526,545 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 74,620 | 74,620 | - | - | Stock Appreciation Right | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 12,084 | 16,731 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 12,084 | 66,212 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 7,115 | 78,296 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 7,115 | 14,979 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 7,115 | 0 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 7,115 | 7,115 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 3,012 | 3,012 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 3,012 | 63,200 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | N. Hazen Samuel | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 78,440 | 296,131 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel Hazen N. | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.55 per share. | 16 Feb 2024 | 30,387 | 265,744 (0%) | 0% | 308.6 | 9,375,909 | Common Stock |
| HCA Healthcare Inc | Hazen N. Samuel | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 79,784 | 79,784 | - | - | Stock Appreciation Right | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 7,864 | 155,923 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 7,864 | 7,864 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 4,647 | 4,647 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 4,647 | 151,276 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 94,880 | 200,557 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 36,770 | 163,787 (0%) | 0% | 262.8 | 9,664,627 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.96 per share. | 03 Feb 2023 | 59,000 | 137,885 (0%) | 0% | 69.0 | 4,068,640 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 59,000 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.08 per share. | 03 Feb 2023 | 32,208 | 105,677 (0%) | 0% | 258.1 | 8,312,241 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 82,880 | 82,880 | - | - | Stock Appreciation Right | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 85,040 | 408,704 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.10 per share. | 18 Feb 2022 | 35,830 | 378,885 (0%) | 0% | 244.1 | 8,746,103 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 6,011 | 414,715 (0%) | 0% | - | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 6,011 | 0 | - | - | Restricted Stock Units | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 86,630 | 86,630 | - | - | Stock Appreciation Right | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.97 per share. | 29 Oct 2021 | 152,625 | 451,454 (0%) | 0% | 48.0 | 7,321,421 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2021 | 82,500 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 250.46 per share. | 29 Oct 2021 | 77,790 | 373,664 (0%) | 0% | 250.5 | 19,483,283 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2021 | 70,125 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 251.84 per share. | 29 Oct 2021 | 38,260 | 326,823 (0%) | 0% | 251.8 | 9,635,230 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 250.96 per share. | 29 Oct 2021 | 8,581 | 365,083 (0%) | 0% | 251.0 | 2,153,528 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 252.44 per share. | 29 Oct 2021 | 3,159 | 323,664 (0%) | 0% | 252.4 | 797,465 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 48,635 | 317,111 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 174.61 per share. | 18 Feb 2021 | 18,282 | 298,829 (0%) | 0% | 174.6 | 3,192,220 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 6,011 | 6,011 | - | - | Restricted Stock Units | |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 130,720 | 130,720 | - | - | Stock Appreciation Right | |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.95 per share. | 03 Nov 2020 | 250,000 | 432,641 (0%) | 0% | 23.0 | 5,737,500 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.09 per share. | 03 Nov 2020 | 227,540 | 390,351 (0%) | 0% | 136.1 | 30,965,919 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.18 per share. | 03 Nov 2020 | 185,250 | 617,891 (0%) | 0% | 37.2 | 6,887,595 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 125,000 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 125,000 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 95,000 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.33 per share. | 03 Nov 2020 | 93,750 | 154,516 (0%) | 0% | 17.3 | 1,624,688 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 90,250 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Sale of securities on an exchange or to another person at price $ 135.90 per share. | 03 Nov 2020 | 72,776 | 312,575 (0%) | 0% | 135.9 | 9,890,440 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 46,875 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 46,875 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Sale of securities on an exchange or to another person at price $ 135.02 per share. | 03 Nov 2020 | 44,099 | 268,476 (0%) | 0% | 135.0 | 5,954,234 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 15,625 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.35 per share. | 03 Nov 2020 | 15,625 | 170,141 (0%) | 0% | 21.4 | 333,594 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.10 per share. | 03 Nov 2020 | 12,500 | 182,641 (0%) | 0% | 22.1 | 276,250 | Common Stock |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 12,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| HCA Healthcare Inc | Samuel N. Hazen | CEO | Sale of securities on an exchange or to another person at price $ 136.63 per share. | 03 Nov 2020 | 5,000 | 385,351 (0%) | 0% | 136.6 | 683,165 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges